ralmitaront
- Generic Name
- ralmitaront
18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in Participants With Schizophrenia
- Conditions
- Schizophrenia
- Interventions
- First Posted Date
- 2025-03-17
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 35
- Registration Number
- NCT06880328
- Locations
- ๐บ๐ธ
Parexel California Clinical Trials Medical Group, Glendale, California, United States
๐บ๐ธCollaborative Neuroscience Network Inc., Torrance, California, United States
๐บ๐ธCBH Health, Gaithersburg, Maryland, United States
A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder
- Conditions
- Schizophrenia, Schizoaffective Disorder
- Interventions
- First Posted Date
- 2020-08-13
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 287
- Registration Number
- NCT04512066
- Locations
- ๐บ๐ธ
CNRI - Los Angeles, LLC, Pico Rivera, California, United States
๐บ๐ธNeuro-Behavioral Clinical Research, Inc., Canton, Ohio, United States
๐บ๐ธUptown Research Institute, Chicago, Illinois, United States
A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms
- Conditions
- Schizophrenia, Schizoaffective Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2018-09-13
- Last Posted Date
- 2024-08-12
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 131
- Registration Number
- NCT03669640
- Locations
- ๐บ๐ธ
California Neuropsychopharmacology Clinical Research Institute, LLC, San Diego, California, United States
๐บ๐ธSynergy San Diego, Lemon Grove, California, United States
๐บ๐ธEmory University, Atlanta, Georgia, United States
The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RO6889450 in Healthy Volunteers
- First Posted Date
- 2016-03-04
- Last Posted Date
- 2017-11-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 164
- Registration Number
- NCT02699372
- Locations
- ๐ณ๐ฑ
PRA Health Sciences Early Development Services, Zuidlaren, Netherlands
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.